Congenital Heart Defects: Prostaglandins and Prostaglandin Inhibitors
Topic Overview
Normally, a blood vessel needed only for
fetal blood circulation
(called the ductus arteriosus) closes off at birth.
During fetal development, this blood vessel is kept open by a naturally
occurring substance in the fetus's body called prostaglandin. At birth, fetal
production of prostaglandin decreases and the ductus arteriosus closes.
In some premature infants, this blood vessel does not close. This is a condition called a patent (open) ductus arteriosus. These premature infants are given a prostaglandin inhibitor, a medicine to stimulate the closure of this blood vessel.
When an infant has certain other congenital heart defects, a medicine (a form of prostaglandin) is often given by vein to keep the ductus arteriosus open. Keeping this blood vessel open allows the blood to continue circulating until surgery or another procedure can be done to correct the related defect and allow normal blood flow.
Related Information
Credits
| By | Healthwise Staff |
| Primary Medical Reviewer | John Pope, MD - Pediatrics |
| Specialist Medical Reviewer | Larry A. Latson, MD - Pediatric Cardiology |
| Last Revised | October 11, 2011 |
| By: | Healthwise Staff | Last Revised: October 11, 2011 |
| Medical Review: | John Pope, MD - Pediatrics Larry A. Latson, MD - Pediatric Cardiology | |
© 1995-, Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated. This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions. | ||
![[+] Feedback [+] Feedback](/iwov-resources/images/sm_565656_oo.gif)
